ArticlePloS one2018

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.

Lucia Lopez-Anglada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.